[HTML][HTML] Efficacy of levofloxacin-based third-line therapy for the eradication of Helicobacter pylori in peptic ulcer disease

JH Lim, SG Kim, JH Song, JJ Hwang, DH Lee… - Gut and …, 2017 - ncbi.nlm.nih.gov
Methods Between 2002 and 2014, 110 patients in 14 medical centers received levofloxacin-
based third-line H. pylori eradication therapy for peptic ulcer disease. Of these, 88 were …

Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease.

JH Song, JH Lim, TH Kim, SM Kim, IK Chung… - Gut & …, 2017 - search.ebscohost.com
Abstract Background/Aims: The resistance rate of Helicobacter pylori is gradually increasing.
We aimed to evaluate the efficacy of levofloxacin-based third-line H. pylori eradication in …

Efficacy of levofloxacin-based third-line therapy for the eradication of helicobacter pylori in peptic ulcer disease

JH Lim, SG Kim, JH Song, JJ Hwang, DH Lee… - Gut and …, 2017 - snucm.elsevierpure.com
Background/Aims: The resistance rate of Helicobacter pylori is gradually increasing. We
aimed to evaluate the efficacy of levofloxacin-based third-line H. pylori eradication in peptic …

Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease

JH LIM, SG KIM, JH SONG, JJ HWANG… - Gut and …, 2017 - pesquisa.bvsalud.org
AIMS: The resistance rate of Helicobacter pylori is gradually increasing. We aimed to
evaluate the efficacy of levofloxacin-based third-line H. pylori eradication in peptic ulcer …

[HTML][HTML] Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease

JH Lim, SG Kim, JH Song, JJ Hwang, DH Lee, JP Han… - Gut and Liver, 2017 - gutnliver.org
Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of <italic>Helicobacter
pylori</italic> in Peptic Ulcer Disease Login to Submission Gut and Liver 2022 Impact Factor …

Efficacy of levofloxacin-based third-line therapy for the eradication of helicobacter pylori in peptic ulcer disease

JH Lim, SG Kim, JH Song, JJ Hwang, DH Lee… - Gut and …, 2017 - pure.ewha.ac.kr
Background/Aims: The resistance rate of Helicobacter pylori is gradually increasing. We
aimed to evaluate the efficacy of levofloxacin-based third-line H. pylori eradication in peptic …

Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease

JH Lim, SG Kim, JH Song, JJ Hwang, DH Lee… - GUT AND …, 2017 - scholarworks.bwise.kr
Background/Aims: The resistance rate of Helicobacter pylori is gradually increasing. We
aimed to evaluate the efficacy of levofloxacin-based third-line H. pylori eradication in peptic …

[PDF][PDF] Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease

JH Lim, SG Kim, JH Song, JJ Hwang, DH Lee, JP Han… - researchgate.net
Background/Aims: The resistance rate of Helicobacter pylori is gradually increasing. We
aimed to evaluate the efficacy of levofloxacin-based third-line H. pylori eradication in peptic …

Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease

JH Lim, SG Kim, JH Song, JJ Hwang, DH Lee… - Gut and …, 2017 - oldkmbase.medric.or.kr
Background/Aims: The resistance rate of Helicobacter pylori is gradually increasing. We
aimed to evaluate the efficacy of levofloxacin-based third-line H. pylori eradication in peptic …

Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease.

JH Lim, SG Kim, JH Song, JJ Hwang, DH Lee… - Gut and …, 2017 - wprim.whocc.org.cn
BACKGROUND/AIMS: The resistance rate of Helicobacter pylori is gradually increasing. We
aimed to evaluate the efficacy of levofloxacin-based third-line H. pylori eradication in peptic …